Showing results (461-470 of 6,709) with videos related to
Sort By:
Pageof 671
Oncotargets and Therapy|November 10, 2018
Targeting VEGF pathway to normalize the vasculature: an emerging insight in cancer therapyJing-Biao Wu, Ya-Ling Tang, Xin-Hua LiangOncotargets and Therapy|November 10, 2018
Inhibition of miR-10a-5p suppresses cholangiocarcinoma cell growth through downregulation of Akt pathwayLili Gao, Xiaoping Yang, Hao Zhang, et al.Oncotargets and Therapy|November 10, 2018
TIM-3, a promising target for cancer immunotherapyYayi He, Jie Cao, Chao Zhao, et al.Oncotargets and Therapy|November 10, 2018
Platelet-to-lymphocyte ratio and lymphocyte-to-white blood cell ratio predict the efficacy of neoadjuvant chemotherapy and the prognosis of locally advanced gastric cancer patients treated with the oxaliplatin and capecitabine regimenCheng Tang, Xi Cheng, Shan Yu, et al.Oncotargets and Therapy|November 10, 2018
MicroRNA-195: a review of its role in cancersWanpeng Yu, Xiao Liang, Xiangdong Li, et al.Oncotargets and Therapy|March 14, 2019
High-intensity focused ultrasound enhances the effect of bufalin by inducing apoptosis in pancreatic cancer cellsZhouyu Ning, Zhenfeng Zhu, Haiyong Wang, et al.Oncotargets and Therapy|March 14, 2019
Up-regulation of CKAP2L expression promotes lung adenocarcinoma invasion and is associated with poor prognosisGuosheng Xiong, Liyin Li, Xiaobo Chen, et al.Oncotargets and Therapy|March 14, 2019
Knockdown of EIF3C promotes human U-2OS cells apoptosis through increased CASP3/7 and Chk1/2 by upregulating SAPK/JNKWeilu Gao, Yong Hu, Zhengqin Zhang, et al.Oncotargets and Therapy|March 14, 2019
Upregulation of STC2 in colorectal cancer and its clinicopathological significanceChunxiao Zhang, Shuangqian Chen, Xiang Ma, et al.Oncotargets and Therapy|March 14, 2019
Moderate hypofractionated radiotherapy vs conventional fractionated radiotherapy in localized prostate cancer: a systemic review and meta-analysis from Phase III randomized trialsZhenzhen Yin, Jinqiang You, Youyou Wang, et al.Pageof 671